Statement Of Changes In Equity [Abstract]

Optomed Oyj - Filing #2160892

Concept	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	—	20,361,000 EUR	31,493,000 EUR	—	—	504,000 EUR	80,000 EUR	334,000 EUR	—	50,936,000 EUR	20,342,000 EUR	—	—	504,000 EUR	27,189,000 EUR	80,000 EUR	51,000 EUR	46,896,000 EUR	—	—	21,970,000 EUR	17,052,000 EUR	38,526,000 EUR	504,000 EUR	88,000 EUR	80,000 EUR
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	4,441,000 EUR	—	—	4,441,000 EUR	—	—	—	—	—	—	—	5,472,000 EUR	5,472,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—
Other comprehensive income	283,000 EUR	—	—	—	—	—	—	—	—	—	—	139,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Comprehensive income	4,157,000 EUR	—	—	4,441,000 EUR	283,000 EUR	—	—	—	—	—	—	5,333,000 EUR	5,472,000 EUR	—	—	—	—	—	—	139,000 EUR	—	—	—	—	—	—
Issue of equity	3,973,000 EUR	—	—	—	—	—	—	—	3,973,000 EUR	—	—	8,200,000 EUR	—	—	—	—	—	—	8,200,000 EUR	—	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	48,000 EUR	—	—	—	—	—	—	—	48,000 EUR	—	—	41,000 EUR	—	—	—	—	—	—	41,000 EUR	—	—	—	—	—	—	—